Clinical significance of immunohistochemically detectable lymph node metastasis in adenocarcinoma of the ampulla of Vater

British Journal of Surgery

Volumn 93, Issue 2, 2006, Pages 221-225

  Mizuno, T ^a   Ishizaki, Y ^a   Ogura, K ^a   Yoshimoto, J ^a   Kawasaki, S ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; CYTOKERATIN ANTIBODY; EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; VATER PAPILLA; VATER PAPILLA CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SURVIVAL ANALYSIS;

EID: 32944482368     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.5226     Document Type: Article

References (36)

1. Warren KW, Choe DS, Plaza J, Relihan M. Results of radical resection for periampullary cancer. Ann Surg 1975; 181: 534-540.
2. Forrest JF, Longmire WP Jr. Carcinoma of the pancreas and periampullary region. Ann Surg 1979; 189: 129-138.
3. Tarazi RY, Hermann RE, Vogt DP, Hoerr SO, Esselstyn CB Jr, Cooperman AM et al. Results of surgical treatment of periampullary tumors; a thirty-five year experience. Surgery 1986; 100: 716-723.
4. Neoptolemos JP, Talbot IC, Carr-Locke DL, Shaw DE, Cockleburgh R, Hall AW et al. Treatment and outcome in 52 consecutive cases of ampullary carcinoma. Br J Surg 1987; 74: 957-961.
5. Shutze WP, Sack J, Aldrete JS. Long-term follow-up of 24 patients undergoing radical resection for ampullary carcinoma, 1953 to 1988. Cancer 1990; 66: 1717-1720.
6. Monson JR, Donohue JH, McEntee GP, McIlrath DC, van Heerden JA, Shorter RG et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg 1991; 126: 353-357.
7. Willett CG, Warshaw AL, Convery K, Compton CC. Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma. Surg Gynecol Obstet 1993; 176: 33-38.
8. Sperti C, Pasquali C, Piccoli A, Sernagiotto C, Pedrazzoli S. Radical resection for ampullary carcinoma: long-term results. Br J Surg 1994; 81: 668-671.
9. Allema JH, Reinders ME, van Gulik TM, van Leeuwen DJ, Verbeek PC, de Wit LT et al. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival. Surgery 1995; 117: 247-253.
10. Chan C, Herrera MF, de la Garza L, Quintanilla-Martinez L, Vargas-Vorackova F, Richaud-Patin Y et al. Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg 1995; 222: 632-637.
11. Klempnauer J, Ridder GJ, Pichlmayr R. Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br J Surg 1995; 82: 1686-1691.
12. Roder JD, Schneider PM, Stein HJ, Siewert JR. Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg 1995; 82: 1693-1696.
13. el-Ghazzawy AG, Wade TP, Virgo KS, Johnson FE. Recent experience with cancer of the ampulla of Vater in a national hospital group. Am Surg 1995; 61: 607-611.
14. Chareton B, Coiffic J, Landen S, Bardaxoglou E, Campion JP, Launois B. Diagnosis and therapy for ampullary tumors: 63 cases. World J Surg 1996; 20: 707-712.
15. Talamini MA, Moesinger RC, Pitt HA, Sohn TA, Hruban RH, Lillemoe KD et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 1997; 225: 590-600.
16. Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Miyazaki I. Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery 1997; 121: 611-617.
17. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 1998; 227: 821-831.
18. Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF. Factors predictive of survival in ampullary carcinoma. Ann Surg 1998; 228: 87-94.
19. Toh SK, Davies N, Dolan P, Worthley C, Townsend N, Williams JA. Good outcome from surgery for ampullary tumour. Aust N Z J Surg 1999; 69: 195-198.
20. Lee JH, Whittington R, Williams NN, Berry MF, Vaughn DJ, Haller DG et al. Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys 2000; 47: 945-953.
21. Mehta VK, Fisher GA, Ford JM, Poen JC, Vierra MA, Oberhelman HA et al. Adjuvant chemoradiotherapy for 'unfavorable' carcinoma of the ampulla of Vater: preliminary report. Arch Surg 2001; 136: 65-69.
22. van Geenen RC, van Gulik TM, Offerhaus GJ, de Wit LT, Busch OR, Obertop H et al. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update. Eur J Surg Oncol 2001; 27: 549-557.
23. Duffy JP, Hines OJ, Liu JH, Ko CY, Cortina G, Isacoff WH et al. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections. Arch Surg 2003; 138: 941-950.
24. Sato F, Shimada Y, Li Z, Watanabe M, Maeda M, Imamura M. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg 2001; 88: 426-432.
25. Vazquez-Sequeiros E, Wang L, Burgart L, Harmsen W, Zinsmeister A, Allen M et al. Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma. Gastroenterology 2002; 122: 2815-2821.
26. Lee E, Chae Y, Kim I, Choi J, Yeom B, Leong AS. Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma. Cancer 2002; 94: 2867-2873.
27. Cai J, Ikeguchi M, Maeta M, Kaibara N. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer. Surgery 2000; 127: 32-39.
28. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibody against cytokeratin and CC49. Cancer 1994; 73: 563-569.
29. Oberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes stages A and B colorectal cancer? Dis Colon Rectum 1998; 41: 1244-1249.
30. Yokoyama N, Shirai Y, Hatakeyama K. Immunohistochemical detection of lymph node micrometastases from gallbladder carcinoma using monoclonal anticytokeratin antibody. Cancer 1999; 85: 1465-1469.
31. Nagakura S, Shirai Y, Yokoyama N, Hatakeyama K. Clinical significance of lymph node micrometastasis in gallbladder carcinoma. Surgery 2001; 129: 704-713.
32. Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg 2003; 237: 201-207.
33. de Castro SM, van Heek NT, Kuhlmann KF, Busch OR, Offerhaus GJ, van Gulik TM et al. Surgical management of neoplasms of the ampulla of Vater: local resection or pancreaticoduodenectomy and prognostic factors for survival. Surgery 2004; 136: 994-1002.
34. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997; 226: 248-260.
35. Neoptolemos JP, Russell RC, Bramhall S, Theis B. Low mortality following resection for pancreatic and periampullary tumors in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg 1997; 84: 1370-1376.
36. Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002; 236: 355-368.